It has been shown that in selenium-treated cancer cells, overexpression of GRP78 diminished selenium-induced CHOP and the subsequent apoptosis [15], whereas knockdown of GRP78 further raised the CHOP expression and enhanced the effect of selenium [33]. The gene discussed is DDIT3; the disease is cancer.